TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 1 | 11 | 44 | 119 | 212 | 184 | 95 |
| P | %wins | 50 | 50 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/16/13 17:09 | 8/16/13 | INSY | Insys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Babich Michael L | AZ | DO | P,CEO | P | 25 | 24.90 | 8 | 1 | 1 | 79 | D | 189 | 216 | 159 | 124 | 67 | 29 | 41 | 37 | 3 | 22 | 51 | 82 | 123 | 114 |
6/4/13 20:28 | 6/4/13 | INSY | Insys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Babich Michael L | AZ | DO | P,CEO | P | 14 | 10.93 | 3 | 1 | 2 | 78 | D | -44 | 4 | 36 | 10 | -14 | -3 | 8 | 2 | -1 | -1 | 36 | 155 | 301 | 254 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |